Acardiac twinning is the most extreme form of twin-twin transfusion syndrome occurring in monozygotic twin pregnancies with monochorionic placentation. Acardius amorphous is the fetus, which has no recognizable human form. The case was referred at 18 weeks' gestation because of an abnormal triple test. Serial sonography scans revealed a growing oval mass around the placenta and polyhydramnios. At term, the amniotic fluid volume was normal, and there was not any detectable blood flow in the mass. Pathological examination showed an acardius amorphous twin containing rudimentary tissues inside the body. The case with a prenatal diagnosis of a placental mass and a high serum level of alpha-fetoprotein and human chorionic gonadotropin should have a differential diagnosis of acardius amorphus. Color Doppler sonography plays an important role in diagnosis and follow-up.
Key words: Doppler ultrasound, placental mass, acardius amorphous, twin-twin transfusion syndrome, acardiac twin the other, leading to reversed arterial blood flow in the perfused twin. 2. The low blood pressure in the recipient twin may cause a secondary disruption of the organ morphogenesis. It may be a primary defect in embryogenesis. 2 The distribution of anomalies has led to the classification of four different morphologic types of acardiac twinning: 3 1. Acardius amorphous: This is the least differentiated form. On histologic analysis, only bones, cartilage, muscles, fat, blood vessels, and stroma can be identified. 2. Acardius acormus: This type of acardiac fetus lacks a thorax. The umbilical cord inserts in the head. 3. Acardius acephalus: This type of acardiac fetus lacks a head, a thorax, and upper extremities. It is the most common type described. 4. Acardius anceps: These types of fetuses have a head, a thorax, and abdominal organs but lack even a rudimentary heart.
The misdiagnosis at sonographic examination is possible because in some cases, the acardiac twin has a tumoral form. 4 It may also be reabsorbed, indicating that the real incidence of this condition might be higher. 5 Neonatal mortality of pump twins in antenatally diagnosed acardiac twin pregnancies may be considerably less than reported. 6 We report second-and third-trimester sonographic findings, pathology, and biochemical and cytogenetic studies of an acardius amorphous twin that presented a placental mass.
Case Report
A woman in her early 30s, gravida 2, para 1, was referred at 18 weeks of gestation for a detailed sonographic examination due to elevated hormone levels in a triple test (MSAFP: 6.6 MoM, free beta-hCG: 4 MoM, unconjugated oestriol [uE 3 ]: 1.2 MoM). Fetal growth was appropriate for gestational age, and amniotic fluid volume was normal. There was a 22 × 20-mm solid, intra-amniotic mass close to the placental insertion of the umbilical cord. An amniocentesis revealed normal chromosomes. At 26 weeks, the mass was enlarged to 50 mm in diameter, and amniotic fluid volume was elevated ( Fig. 1) . At 30 weeks, the patient was hospitalized for preterm labor due to polyhydramnios (amniotic fluid index > 30 mm). The mass was 70 × 48 mm and had a cystic component, and scattered arterial flow was detected with power Doppler sonography (Fig. 2) . The patient was treated with tocolytic agents and therapeutic amniocentesis. At 38 weeks, the mass was 91 mm in diameter, and the amniotic volume was normal. Doppler sonographic examination of the mass showed no blood flow. The patient delivered a male baby weighing 2850 g. The mass was attached to the placenta at the insertion site of the umbilical cord ( Fig. 3) . Pathological examination revealed a dysplastic kidney, adrenal glands, parts of the gastrointestinal 
Discussion
The prenatal diagnosis of acardiac twins is based on these sonographic findings: biometric discordance between the twins; the absence of identifiable cardiac pulsation in one twin; poor definition of the head, trunk, and upper extremities; deformed lower extremities; marked and diffuse subcutaneous edema; and abnormal cystic areas in the upper part of the body of the affected twin. 7 In some cases, the acardiac twin may be a shapeless mass of tissue containing no recognizable organs, as in our case.
In cases of placental solid masses protruding from the fetal surface identified during the sonographic examination, the main differential diagnoses are chorioangioma and subchorionic hematoma. 8 The initial diagnosis was chorioangioma because there are case reports of elevated serum markers and amniotic fluid volume as a result of the presence of this vascularized solid mass. 9 Placental hematomas that are always avascular might have a similar sonographic appearance, but the use of color Doppler imaging helped in the differential diagnosis.
The prenatal diagnosis of an oval mass around the placenta should also include a differential diagnosis of acardius amorphus. 10 A distinction between the placental teratoma and acardius amorphus could be made by sonographic examination. Two sonographic criteria can be used to differentiate between a teratoma and an acardiac twin prenatally. First, an acardiac twin always has a separate, though rudimentary, umbilical cord; second, the twin shows some evidence of body organization. 11 In our case, the presence of the umbilical cord with a single artery and a single vein was detected after delivery.
The flow pattern leading to acardia has been described as the twin reversed arterial perfusion sequence. The blood of the pump twin, which is relatively deoxygenated and poor in nutrients, flows via its umbilical arteries to the placenta and then via artery-to-artery anastomoses in a retrograde direction through the umbilical arteries of the acardiac twin. The anatomically normal (pump) twin is at great risk for high-output congestive heart failure and hydrops fetalis. The mortality may be as high as 55%. 12 Attempts to identify factors that predict pump fetus outcome originally focused on the structure of the acardiac twin. The size of the acardiac twin and the cardiovascular status of the pump twin are the most important factors to predict pump-twin outcome and guide management. 6 High renal perfusion in the pump twin may cause polyhydramnios and preterm delivery. 13 Excess amniotic fluid may also be a result of transudation through the wall of the abnormal vessels in the mass. Assessing the vascularity in the acardiac mass may help in predicting whether the size of the mass will increase or decrease. 6 Cessation of flow in the acardiac twin in our case improved the prognosis of the pump twin. Amniotic fluid volume was also dramatically reduced after this event.
Conclusion
Elevated serum biochemical markers, polyhydramnios, and a growing placental mass are findings of an acardiac twin. Monitoring the size, blood flow, and amniotic fluid volume with serial sonographic examinations is an important part of management.
